Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma

European Journal of Surgical Oncology

Volumn 28, Issue 1, 2002, Pages 80-87

  Begossi, G ^a   Gonzalez Moreno, S ^a   Ortega Perez, G ^a   Fon, L J ^a   Sugarbaker, Paul H ^a,b  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

5 fluorouracil; Cancer seeding; Electrosurgery; Hyperthemia; Intraperitoneal chemotherapy; Mitomycin C; Surgical oncology

Indexed keywords

FLUOROURACIL; MITOMYCIN C; ANTINEOPLASTIC AGENT;

CARCINOMATOUS PERITONITIS; CHEMOTHERAPY; COLON RESECTION; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; ELECTROSURGERY; HUMAN; MESOTHELIOMA; MORBIDITY; MORTALITY; PATIENT POSITIONING; PATIENT SELECTION; PERIOPERATIVE PERIOD; PLASTIC SURGERY; PRIORITY JOURNAL; REVIEW; SARCOMA; SPLENECTOMY; SURVIVAL TIME; TREATMENT OUTCOME; ARTICLE; CARCINOMA; CHOLECYSTECTOMY; HYPERTHERMIC THERAPY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PERITONEUM; PERITONEUM LAVAGE; PERITONEUM TUMOR; POSTOPERATIVE COMPLICATION; REOPERATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHOLECYSTECTOMY; COLECTOMY; COMBINED MODALITY THERAPY; ELECTROSURGERY; HUMANS; HYPERTHERMIA, INDUCED; MESOTHELIOMA; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PERITONEUM; POSTOPERATIVE COMPLICATIONS; REOPERATION; SARCOMA; SPLENECTOMY;

EID: 0036482517     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1152     Document Type: Review

References (32)

1. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 1994; 81: 7-19.
2. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Semin Oncol 1999; 26: 536-9.
3. Fortner JG. Inadvertent spread of cancer at surgery. J Surg Oncol 1993; 53: 191-6.
4. Koga S, Kaibare N, Litsuka Y, Kudo H, Kumura A, Kiraka H. Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients. J Cancer Res Clin Oncol 1984; 108: 236-8.
5. Baba H, Korenaga D, Haraguchi M, Okamura T, Saito A, Watanabe A, Sugimachi K. Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion. Cancer 1989; 64: 2482-6.
6. Haraguchi M, Watanabe A, Kakeji Y, Tsujitani S, Baba H, Maehara Y, Sugimachi K. Prognostic significance of serosal invasion in carcinoma of the stomach. Surg Gynecol Obstet 1991; 172: 29-32.
7. Zeng Z, Cohen A, Hajdu S, et al. Serosal cytological study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer 1992; 70: 737-40.
8. Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg Oncol 1995; 130: 387-93.
9. Izuka Y, Kaneshita S, Taneda O, Takeuchi T, Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer 1979; 44: 1476-86.
10. Tanida O, Kaneshima S, Izuka Y, Kuda H, Kigasu Y, Koga S. Viability of intraperitoneal free cancer cells in patients with gastric carcinoma. Acta Cytol 1982; 26: 681-7.
11. Savalgi RS. Mechanism of abdominal wall recurrence following laparoscopic resection of colonic cancers. Sem Lap Surg 1995; 2: 158.
12. Sugarbaker PH. Laser-node electrosurgery. In: Sugarbaker PH (ed). Peritoneal carcinomatosis: principles of management Boston: Kluwer Academic Publishers, 1996; pp. 375-85.
13. Howell SB, Pfeifle CL, Wung WE, et al. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845.
14. Hayashi T, Nasu Y, Aramaki K, Johnsen T, Matsuura H. A case of peritoneal malignant mesothelioma with disappearance of ascites result of intraperitoneal instillation of mitomycin C and oral administration of UFT. Gan To Kagaku Ryoho 1989; 16: 2449-52.
15. Sugarbaker PH, Cunliffe WJ, Graves T, et al. Phase I and pharmacologic studies with early postoperative intraperitoneal epiadriamycin. Fourth International Conference on Advances in Regional Cancer Therapy. Berchtesgaden, Germany, 1989.
16. Fernandez-Trigo V, Stuart OA, Stephen AD, Hoover LD, Sugarbaker PH. Surgically directed chemotherapy: Heated intraperitoneal lavage with mitomycin C. In: Sugarbaker PH (ed). Peritoneal carcinomatosis: Drugs and disease. Kluwer: Boston, 1996; pp. 51-61.
17. Stephens AD, Belliveau J, Sugarbaker PH. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis. In: Sugarbaker PH (ed). Peritoneal carcinomatosis: Drugs and disease. Kluwer: Boston, 1996; pp. 15-30.
18. Stuart OA, Stephens AD, Welch L, Sugarbaker PH. Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol (in press).
19. White SK, Stephens AD, Sugarbaker PH. Hyperthermic intraoperative intraperitoneal chemotherapy safety consideration. AORN J 1996; 63: 716-24.
20. Zoetmulder FAN, Sugarbaker PH. Pattern of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer 1996; 32: 1727-33.
21. Hughes ESR, McDermott FT, Polglase L, et al. Tumor recurrence in the abdominal wall scar tissue after large-bowel cancer surgery. Dis Colon Rectum 1983; 26: 571.
22. Esquivel JE, Sugarbaker PH. Elective surgery in recurrent colon cancer with peritoneal seeding: When to and when not to operate (Editorial). Cancer Therapeutics 1998; 1: 321-5.
23. Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999; 43 (Suppl): S15-S25.
24. Stephens AD, Alderman R, Chang D, Edwards GD, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the Coliseum technique. Ann Surg Oncol 1999; 6: 790-6.
25. Cavaliere F, Di Filippo F, Botti C, Cosimelli M, et al. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Oncol 2000; 26: 486-91.
26. Markman M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol Obstet 1987; 164: 89.
27. Los G, Verdegaal EM, Mutsaers PH, McVie JG. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 1991; 28: 159-65.
28. Los G, van Vugt MJH, Pinedo HM. Potentiation of i.p. chemotherapy by abdominal hyperthermia in rats. 83rd Annual Meeting of the AACR. San Diego, California 1992, 33: 2980.
29. Panteix G, Guillamont M, Cherpin L, Cuichard J, Gilly FN, et al. Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology 1993; 50: 366-70.
30. Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemo-hyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996; 199: 437-44.
31. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined surgery. Cancer 1997; 79: 884-91.
32. Sayag-Beaujard AC, Francois Y, Glehen O, et al. Intraperitoneal chemo-hyperthermia with Mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res 1999; 19: 1375-82.